Andropause: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 24: Line 24:


== Screening==
== Screening==
Several questionnaires have been developed as a screening tool for andropause. These questionnaires include the following:
* St. Louis University’s ADAM<ref name="pmid11016912">{{cite journal| author=Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D et al.| title=Validation of a screening questionnaire for androgen deficiency in aging males. | journal=Metabolism | year= 2000 | volume= 49 | issue= 9 | pages= 1239-42 | pmid=11016912 | doi=10.1053/meta.2000.8625 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=11016912  }} </ref><ref name="pmid19657348">{{cite journal| author=Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI et al.| title=The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism. | journal=Int J Impot Res | year= 2010 | volume= 22 | issue= 1 | pages= 20-4 | pmid=19657348 | doi=10.1038/ijir.2009.35 | pmc=PMC2834355 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=19657348  }} </ref>
* The Aging Male Survey (AMS)<ref name="pmid17558969">{{cite journal| author=Morales A, Spevack M, Emerson L, Kuzmarov I, Casey R, Black A et al.| title=Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry. | journal=Aging Male | year= 2007 | volume= 10 | issue= 2 | pages= 57-65 | pmid=17558969 | doi=10.1080/13685530701342686 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17558969  }} </ref>
* The MMAS<ref name="pmid15236757">{{cite journal| author=O'Donnell AB, Araujo AB, McKinlay JB| title=The health of normally aging men: The Massachusetts Male Aging Study (1987-2004). | journal=Exp Gerontol | year= 2004 | volume= 39 | issue= 7 | pages= 975-84 | pmid=15236757 | doi=10.1016/j.exger.2004.03.023 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15236757  }} </ref>


==Natural History, Complications and Prognosis==
==Natural History, Complications and Prognosis==

Revision as of 16:25, 24 March 2013

Template:Search infobox Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Overview

Andropause may or may not actually exist as a clinical phenomenon. Its proponents claim it is a biological change experienced by men during their mid-life, and is often inaccurately compared to the female menopause. It would perhaps be more reasonable to speak of a steady age-related decline in testosterone levels in men, since men's reproductive systems slowly and gradually decline with age, but do not stop working altogether in mid-life, as women's do. It is also not clear how much this supposedly universal male phenomenon can be related to a psychological mid-life crisis, and to overall negative bodily changes in mid-life due not only to aging, but also to the accumulated effects of a lack of exercise, poor diet and so on. Andropause is also known as androgen decline in the aging male (ADAM), late onset hypogonadism (LOH) and testosterone deficiency syndrome (TDS). There is no cut off age point at which andropause starts as there is variability among men in terms of age of onset. Endocrine Society Guideline and the European Association of Urology Recommendations defines andropause as the following: TDS/LOH is a clinical and biochemical syndrome associated with advancing age and characterized by symptoms and a deficiency in serum T levels. It may result in significant detriment in the quality of life and adversely affect the function of multiple organ systems.[1]

Historical Perspective

Much of the current interest in this alleged phenomenon has been fueled by the book Male Menopause, written by Jed Diamond[2]. It should be noted that Diamond is neither an MD nor a PhD. According to the book's author, andropause (another term for "male menopause") is a change of life in middle-aged men, which has hormonal, physical, psychological, interpersonal, social, sexual, and spiritual aspects. Diamond claims that this change occurs in all men, generally between the ages of 40 and 55, though it can occur as early as 35 or as late as 65.

The term "male menopause" is a misnomer, as men don’t have menstrual periods, and therefore cannot stop having them. Unlike women, men's reproductive systems do not cease to work completely in mid-life; some men continue to father children late into their lives (at age 90 or older[3]). But Diamond claims that, in terms of other life impacts, women’s and men’s experience are somewhat similar phenomena.[4][5][6]

The concept of andropause is perhaps more widely accepted in Australia and some parts of Europe than it is in the United States[7]. In the U.S., many clinicians believe that, since men can continue to reproduce into old age, and do not show the same dramatic drops in hormone levels characteristic of menopause in women, andropause is nonexistent. Others feel that andropause is real, but is synonymous with hypogonadism or low testosterone levels [8].

Pathophysiology

  • Aging affects the hypothalamus- pituitary- gonadal axis and causes a decrease in the production of gonadotropin releasing hormone (GnRH) by the hypothalamus(Morales A, Heaton JP. Hypogonadism and erectile dysfunction: pathophy­ siological observations and therapeutic outcomes. BJU Int 2003;92: 896–9.) and a decrease in the production of LH by the pituitary. [9]
  • Aging is associated with decrease in the number Leydig cells as well as decrease in their sensitivity to LH resulting in decrease production of testosterone.[10]
  • Age related changes in androgen receptor, a ligand­ inducible transcription factor, has been reported to be associated with less androgenic effects of the testosterone.[11]

Epidemiology and Demographics

The prevalence of andropause has not been accurately reported. According to the Massachusetts Male Aging Study (MMAS) has estimated the crude prevalence of andropause in American men between 40 and 69 years old to be around 481,000 new cases per.[1]

Screening

Several questionnaires have been developed as a screening tool for andropause. These questionnaires include the following:

  • St. Louis University’s ADAM[12][13]
  • The Aging Male Survey (AMS)[14]
  • The MMAS[15]

Natural History, Complications and Prognosis

Symptoms

The impact of low levels of testosterone has been previously reported. Heller and Myers[16] identified symptoms of what they labeled the "male climacteric" including loss of libido and potency, nervousness, depression, impaired memory, the inability to concentrate, fatigue, insomnia, hot flushes, and sweating. Heller and Myers found that their subjects had lower than normal levels of testosterone, and that symptoms improved dramatically when patients were given replacement doses of testosterone.

Testosterone deficiency has also been linked to metabolic syndrome[17] and mood disturbances mainly depression[18].

Diagnosis

Treatment

Several intervention strategies have been found to be effective[19] [20] [21][22]. These include:

  • Hormone replacement therapy,
  • Exercise, dietary changes, stress reduction,
  • Couple counseling, career refocusing, and spiritual support,
  • Chemical dependency treatment, sexual compulsivity treatment,
  • Treatment for depression,
  • Finding and engaging one’s “calling” in the second half of life.

References

  1. ↑ 1.0 1.1 Araujo AB, O'Donnell AB, Brambilla DJ, Simpson WB, Longcope C, Matsumoto AM; et al. (2004). "Prevalence and incidence of androgen deficiency in middle-aged and older men: estimates from the Massachusetts Male Aging Study". J Clin Endocrinol Metab. 89 (12): 5920–6. doi:10.1210/jc.2003-031719. PMID 15579737.
  2. ↑ Diamond, Jed. Male Menopause. Naperville, IL: Sourcebooks, 1997.
  3. ↑ "Father, 90, shows off new baby" - timesonline.co.uk, retrieved 9/08/07
  4. ↑ Cetel, Nancy. Double Menopause. New York: John Wiley, & Sons, 2002.
  5. ↑ Diamond, Jed. Surviving Male Menopause: A Guide for Women and Men. Naperville, IL: Sourcebooks, 2000.
  6. ↑ Tan, Robert S. The Andropause Mystery: Unraveling truths about the Male Menopause. Houston, Texas: AMRED publications, 2001.
  7. ↑ Carruthers, Malcolm. Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment. London & New York: Taylor & Francis, 2004.
  8. ↑ Tan, Robert S. The Andropause Mystery: Unraveling truths about the Male Menopause. Houston, Texas: AMRED publications, 2001.
  9. ↑ Liu PY, Beilin J, Meier C, et al. Age­related changes in serum testosterone and sex hormone binding globulin in Australian men: longitudinal analysis of two geographically separate regional cohorts. J Clin Endocri­ nol Metab 2007;92:3599–603.)
  10. ↑ Chen H, Hardy MP, Zirkin BR (2002). "Age-related decreases in Leydig cell testosterone production are not restored by exposure to LH in vitro". Endocrinology. 143 (5): 1637–42. PMID 11956144.
  11. ↑ Härkönen K, Huhtaniemi I, Mäkinen J, Hübler D, Irjala K, Koskenvuo M; et al. (2003). "The polymorphic androgen receptor gene CAG repeat, pituitary-testicular function and andropausal symptoms in ageing men". Int J Androl. 26 (3): 187–94. PMID 12755998.
  12. ↑ Morley JE, Charlton E, Patrick P, Kaiser FE, Cadeau P, McCready D; et al. (2000). "Validation of a screening questionnaire for androgen deficiency in aging males". Metabolism. 49 (9): 1239–42. doi:10.1053/meta.2000.8625. PMID 11016912.
  13. ↑ Mohamed O, Freundlich RE, Dakik HK, Grober ED, Najari B, Lipshultz LI; et al. (2010). "The quantitative ADAM questionnaire: a new tool in quantifying the severity of hypogonadism". Int J Impot Res. 22 (1): 20–4. doi:10.1038/ijir.2009.35. PMC 2834355. PMID 19657348.
  14. ↑ Morales A, Spevack M, Emerson L, Kuzmarov I, Casey R, Black A; et al. (2007). "Adding to the controversy: pitfalls in the diagnosis of testosterone deficiency syndromes with questionnaires and biochemistry". Aging Male. 10 (2): 57–65. doi:10.1080/13685530701342686. PMID 17558969.
  15. ↑ O'Donnell AB, Araujo AB, McKinlay JB (2004). "The health of normally aging men: The Massachusetts Male Aging Study (1987-2004)". Exp Gerontol. 39 (7): 975–84. doi:10.1016/j.exger.2004.03.023. PMID 15236757.
  16. ↑ Heller, C.G., Myers, G.B., “The Male climacteric: Its symptomatology, diagnosis and treatment.” JAMA 1944; 126:472-77.
  17. ↑ Dandona P, Dhindsa S (2011). "Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity". J Clin Endocrinol Metab. 96 (9): 2643–51. doi:10.1210/jc.2010-2724. PMC 3167667. PMID 21896895.
  18. ↑ DiBlasio CJ, Hammett J, Malcolm JB, Judge BA, Womack JH, Kincade MC; et al. (2008). "Prevalence and predictive factors for the development of de novo psychiatric illness in patients receiving androgen deprivation therapy for prostate cancer". Can J Urol. 15 (5): 4249–56, discussion 4256. PMID 18814813.
  19. ↑ Diamond, Jed. Male Menopause. Naperville, IL: Sourcebooks, 1997.
  20. ↑ Diamond, Jed. Surviving Male Menopause: A Guide for Women and Men. Naperville, IL: Sourcebooks, 2000.
  21. ↑ Diamond, Jed. The Irritable Male Syndrome: Managing the 4 Key Causes of Depression and Aggression. Emmaus, Pa: Rodale Press, 2004.
  22. ↑ Carruthers, Malcolm. Androgen Deficiency in the Adult Male: Causes, Diagnosis and Treatment. London & New York: Taylor & Francis, 2004.

See also

External links

Template:Reproductive physiology
de:Klimakterium virile it:Andropausa he:גיל המעבר אצל גברים uk:Андропауза

Template:WikiDoc Sources

Retrieved from "https://www.wikidoc.org/index.php?title=Andropause&oldid=864205"